Pacific Health Financials
Pacific Health (PFHO) reported $6.7M in revenue for fiscal year 2025, up 10.7% from the prior fiscal year. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 15 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).
Pacific Health Care’s earnings engine is unusually cash-efficient, and its growth appears internally financed rather than balance-sheet driven.
Across FY2023-FY2025, cumulative operating cash flow of$2.8M closely tracked cumulative net income of$3.0M . Free cash flow still totaled$2.7M because capital spending over the same span was only$49K , so reported earnings were not being consumed by heavy reinvestment or working-capital buildup.
From FY2023 to FY2025, operating margin widened from
FY2025 ended with only
Financial Health Signals
Pacific Health does not currently provide enough eligible data for a peer-relative financial health score, so none is published. The signals and metrics below are current.
Pacific Health scores 22.69, well above the 2.99 safe threshold. The score is driven primarily by a large market capitalization ($12.6M) relative to total liabilities ($389K). This indicates low bankruptcy risk based on profitability, leverage, and asset efficiency.
Distress-screening estimate for non-financial companies. Not computed for banks or insurers, where the Altman model does not apply.
Pacific Health passes 6 of 7 computable financial strength tests (2 of the nine could not be computed from available data). 3 of 4 profitability signals pass, all 2 leverage/liquidity signals pass, both operating efficiency signals pass.
For every $1 of reported earnings, Pacific Health generates $0.84 in operating cash flow ($1.2M OCF vs $1.4M net income). This mixed ratio suggests some earnings may rely on non-cash accounting items.
Pacific Health earns $657.71 in operating income for every $1 of interest expense ($1.0M vs $2K). This wide margin provides strong safety for debt servicing, even if earnings decline temporarily.
Key Financial Metrics
Earnings & Revenue
Pacific Health generated $6.7M in revenue in fiscal year 2025. This represents an increase of 10.7% from the prior year.
Pacific Health's EBITDA was $1.0M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization. This represents an increase of 15.6% from the prior year.
Pacific Health reported $1.4M in net income in fiscal year 2025. This represents an increase of 57.0% from the prior year.
Pacific Health earned $0.11 per diluted share (EPS) in fiscal year 2025. This represents an increase of 57.1% from the prior year.
Cash & Balance Sheet
Pacific Health generated $1.1M in free cash flow in fiscal year 2025, representing cash available after capex. This represents an increase of 70.8% from the prior year.
Pacific Health held $2.2M in cash as of fiscal year 2025; long-term debt is not reported for that period.
Not reported for fiscal year 2025.
Margins & Returns
Pacific Health's operating margin was 14.9% in fiscal year 2025, reflecting core business profitability. This is up 0.9 percentage points from the prior year.
Pacific Health's net profit margin was 20.7% in fiscal year 2025, showing the share of revenue converted to profit. This is up 6.1 percentage points from the prior year.
Pacific Health's ROE was 10.6% in fiscal year 2025, measuring profit generated per dollar of shareholder equity. This is up 3.0 percentage points from the prior year.
Not reported for fiscal year 2025.
Capital Allocation
Pacific Health invested $23K in capex in fiscal year 2025, funding long-term assets and infrastructure. This represents an increase of 154.9% from the prior year.
Not reported for fiscal year 2025.
Not reported for fiscal year 2025.
PFHO Income Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type.
| Metric | TTM | FY25 | FY24 | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 | FY11 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $6.4M | $6.7M+10.7% | $6.1M+7.7% | $5.6M-2.0% | $5.7M+6.3% | $5.4M-10.6% | $6.0M-17.6% | $7.3M+7.9% | $6.8M+4.5% | $6.5M+14.4% | $5.7M-30.8% | $8.2M-13.1% | $9.5M+44.0% | $6.6M+36.2% | $4.8M+70.4% | $2.8M |
| Cost of Revenue | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | $513K-5.6% | $543K | N/A | N/A | N/A | N/A | N/A | N/A |
| Gross Profit | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | $6.3M+5.4% | $6.0M | N/A | N/A | N/A | N/A | N/A | N/A |
| SG&A Expenses | $742K | $767K+5.6% | $726K+17.7% | $617K-12.6% | $706K+7.2% | $658K-5.4% | $696K-14.8% | $817K+11.1% | $735K+12.5% | $653K-1.2% | $661K+3.7% | $638K+10.5% | $577K+21.6% | $475K-3.2% | $491K+25.0% | $392K |
| Operating Income | $925K | $1.0M+17.4% | $853K+25.7% | $679K+1.9% | $666K+29.0% | $516K-37.0% | $820K-51.2% | $1.7M-11.1% | $1.9M+12.0% | $1.7M+74.1% | $969K-65.7% | $2.8M-14.4% | $3.3M+60.4% | $2.1M+66.7% | $1.2M+282.6% | $322K |
| Interest Expense | $0 | $2K-57.2% | $4K | $0 | $0+100.0% | -$5K | $0 | N/A | $0 | $0 | $0-100.0% | $202-82.4% | $1K-39.8% | $2K+1.3% | $2K+58.1% | $1K |
| Income Tax | $345K | $507K+33.4% | $380K+18.6% | $321K+59.9% | $200K-0.3% | $201K-25.7% | $271K-43.8% | $482K-9.0% | $530K-26.7% | $723K+79.6% | $403K-64.8% | $1.1M-14.2% | $1.3M+62.5% | $821K+57.3% | $522K+326.2% | $122K |
| Net Income | $979K | $1.4M+57.0% | $884K+15.1% | $768K+55.8% | $493K-50.5% | $995K+81.1% | $550K-54.1% | $1.2M-11.9% | $1.4M+41.0% | $964K+70.2% | $567K-66.2% | $1.7M-14.5% | $2.0M+59.2% | $1.2M+73.3% | $711K+258.9% | $198K |
| EPS (Diluted) | — | $0.11+57.1% | $0.07+16.7% | $0.06+50.0% | $0.04-50.0% | $0.08+100.0% | $0.04-55.6% | $0.09-18.2% | $0.11 | $0.30 | $0.71-66.2% | $2.10-14.3% | $2.45+59.1% | $1.54+73.0% | $0.89+256.0% | $0.25 |
Not reported in any period shown, so not listed: R&D Expenses.
TTM is the trailing twelve months, Q3 FY2025 through Q2 FY2026, summed from the four most recent quarterly filings. A row marked — cannot be summed at all, because a quarter in the window reports no per-share figure; a row marked N/A could be summed, but a quarter in the window does not report that metric.
PFHO Balance Sheet
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type.
| Metric | FY25 | FY24 | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 | FY11 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Assets | $13.5M+8.3% | $12.4M+5.8% | $11.8M-2.5% | $12.1M+6.3% | $11.3M+2.0% | $11.1M+8.3% | $10.3M+20.6% | $8.5M+17.2% | $7.3M+16.0% | $6.3M+13.4% | $5.5M+7.0% | $5.2M+69.9% | $3.0M+48.2% | $2.0M+93.4% | $1.1M |
| Current Assets | $13.4M+8.5% | $12.3M+6.6% | $11.6M-2.7% | $11.9M+6.8% | $11.1M+4.6% | $10.6M+11.6% | $9.5M+14.5% | $8.3M+18.0% | $7.1M+17.7% | $6.0M+15.0% | $5.2M+5.0% | $5.0M+71.4% | $2.9M+54.9% | $1.9M+91.0% | $980K |
| Cash & Equivalents | $2.2M+4.7% | $2.1M-17.0% | $2.5M+22.5% | $2.0M-79.8% | $10.1M+6.2% | $9.5M+17.2% | $8.1M+14.6% | $7.1M+21.6% | $5.8M+16.2% | $5.0M+30.5% | $3.8M+30.2% | $2.9M+132.8% | $1.3M+163.8% | $480K+30.2% | $368K |
| Accounts Receivable | $1.0M-2.3% | $1.0M+0.8% | $1.0M+8.3% | $943K+1.6% | $928K-12.7% | $1.1M-4.6% | $1.1M+18.5% | $940K-9.7% | $1.0M+22.5% | $850K-18.3% | $1.0M-44.3% | $1.9M+23.0% | $1.5M+14.0% | $1.3M+154.4% | $524K |
| Total Liabilities | $389K-47.9% | $746K-21.4% | $948K+29.0% | $735K+44.6% | $508K-60.2% | $1.3M+31.2% | $974K+129.8% | $424K-21.3% | $539K+7.9% | $499K+29.7% | $385K-27.9% | $534K+79.6% | $297K-45.2% | $542K+105.5% | $264K |
| Current Liabilities | $389K-47.9% | $746K-20.4% | $936K+32.1% | $709K+41.4% | $501K-51.9% | $1.0M+52.9% | $682K+60.8% | $424K-21.3% | $539K+7.9% | $499K+29.7% | $385K-27.9% | $534K+84.6% | $289K-44.5% | $520K+102.8% | $257K |
| Total Equity | $13.1M+11.9% | $11.7M+8.2% | $10.8M-4.5% | $11.3M+4.6% | $10.8M+10.1% | $9.8M+5.9% | $9.3M+14.8% | $8.1M+20.2% | $6.7M+16.8% | $5.8M+12.2% | $5.1M+11.0% | $4.6M+68.8% | $2.7M+81.8% | $1.5M+89.4% | $796K |
| Retained Earnings | $12.6M+12.3% | $11.3M+8.5% | $10.4M-4.7% | $10.9M+4.7% | $10.4M+10.6% | $9.4M+6.2% | $8.9M+15.7% | $7.7M+21.6% | $6.3M+18.1% | $5.3M+11.9% | $4.8M+16.8% | $4.1M+92.7% | $2.1M+139.6% | $883K+415.0% | $171K |
Not reported in any period shown, so not listed: Inventory, Goodwill, Long-Term Debt.
PFHO Cash Flow Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type.
| Metric | TTM | FY25 | FY24 | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 | FY11 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $598K | $1.2M+71.9% | $675K-27.6% | $932K+31.1% | $711K+84.1% | $386K-60.9% | $987K-9.5% | $1.1M-17.3% | $1.3M+59.7% | $826K-31.5% | $1.2M-44.3% | $2.2M+15.8% | $1.9M+131.5% | $808K+283.8% | $211K+138.9% | $88K |
| Capital Expenditures | $19K | $23K+154.9% | $9K-47.9% | $18K-54.9% | $39K+111.5% | $18K-65.9% | $54K-9.0% | $59K+41.8% | $42K+150.4% | $17K-60.8% | $42K-73.2% | $158K+57.4% | $101K+3198.6% | $3K-96.5% | $88K+39.4% | $63K |
| Free Cash Flow | $578K | $1.1M+70.8% | $666K-27.2% | $915K+36.1% | $672K+82.7% | $368K-60.6% | $934K-9.5% | $1.0M-19.2% | $1.3M+57.8% | $809K-30.4% | $1.2M-42.0% | $2.0M+13.4% | $1.8M+119.9% | $805K+556.5% | $123K+389.5% | $25K |
| Investing Cash Flow | -$478K | -$990K+12.7% | -$1.1M-240.5% | $807K+109.2% | -$8.8M-47571.8% | -$18K+65.9% | -$54K+9.0% | -$59K-41.8% | -$42K-150.4% | -$17K+60.8% | -$42K+73.2% | -$158K-57.4% | -$101K-3198.6% | -$3K+97.6% | -$126K-100.3% | -$63K |
| Financing Cash Flow | -$36K | -$72K-304.8% | $35K+102.8% | -$1.3M | $0-100.0% | $219K-52.5% | $461K | $0+100.0% | -$20K | $0-100.0% | $7K+100.6% | -$1.1M-1145.0% | -$90K-365.9% | -$19K-171.6% | $27K+538.5% | -$6K |
| Dividends Paid | N/A | $37K | $0-100.0% | $1.3M | $0 | N/A | N/A | $0-100.0% | $20K | $0-100.0% | $2K-99.8% | $934K | $0 | $0 | $0 | N/A |
| Share Buybacks | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | $0-100.0% | $177K+131.2% | $77K | $0 | N/A | N/A |
TTM is the trailing twelve months, Q3 FY2025 through Q2 FY2026, summed from the four most recent quarterly filings. A row marked — cannot be summed at all, because a quarter in the window reports no per-share figure; a row marked N/A could be summed, but a quarter in the window does not report that metric.
PFHO Financial Ratios
Margins and returns are percentages; the remaining ratios are unitless multiples.
| Metric | FY25 | FY24 | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 | FY11 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | N/A | N/A | N/A | N/A | N/A | N/A | N/A | 92.5%+0.8pp | 91.6% | N/A | N/A | N/A | N/A | N/A | N/A |
| Operating Margin | 14.9%+0.9pp | 14.1%+2.0pp | 12.0%+0.5pp | 11.6%+2.0pp | 9.6%-4.0pp | 13.6%-9.3pp | 22.9%-4.9pp | 27.8%+1.9pp | 25.9%+8.9pp | 17.0%-17.3pp | 34.3%-0.5pp | 34.8%+3.6pp | 31.3%+5.7pp | 25.6%+14.2pp | 11.4% |
| Net Margin | 20.7%+6.1pp | 14.6%+0.9pp | 13.6%+5.1pp | 8.6%-9.8pp | 18.4%+9.3pp | 9.1%-7.2pp | 16.3%-3.7pp | 20.0%+5.2pp | 14.8%+4.9pp | 10.0%-10.4pp | 20.4%-0.3pp | 20.7%+2.0pp | 18.8%+4.0pp | 14.7%+7.7pp | 7.0% |
| Return on Equity | 10.6%+3.0pp | 7.6%+0.5pp | 7.1%+2.7pp | 4.4%-4.8pp | 9.2%+3.6pp | 5.6%-7.3pp | 12.9%-3.9pp | 16.8%+2.5pp | 14.3%+4.5pp | 9.8%-22.8pp | 32.7%-9.7pp | 42.4%-2.6pp | 45.0%-2.2pp | 47.2%+22.3pp | 24.9% |
| Return on Assets | 10.3%+3.2pp | 7.1%+0.6pp | 6.5%+2.4pp | 4.1%-4.7pp | 8.8%+3.8pp | 5.0%-6.7pp | 11.7%-4.3pp | 16.0%+2.7pp | 13.3%+4.2pp | 9.1%-21.3pp | 30.4%-7.6pp | 38.0%-2.6pp | 40.6%+5.9pp | 34.7%+16.0pp | 18.7% |
| Current Ratio | 34.45+17.9x | 16.54+4.2x | 12.36-4.4x | 16.78-5.4x | 22.23+12.0x | 10.21-3.8x | 14.00-5.7x | 19.66+6.5x | 13.12+1.1x | 12.03-1.5x | 13.57+4.3x | 9.32-0.7x | 10.04+6.4x | 3.60-0.2x | 3.82 |
| Debt-to-Equity | 0.030.0x | 0.060.0x | 0.090.0x | 0.070.0x | 0.05-0.1x | 0.130.0x | 0.10+0.1x | 0.050.0x | 0.080.0x | 0.090.0x | 0.070.0x | 0.120.0x | 0.11-0.3x | 0.360.0x | 0.33 |
| FCF Margin | 16.9%+6.0pp | 11.0%-5.3pp | 16.3%+4.5pp | 11.7%+4.9pp | 6.8%-8.6pp | 15.4%+1.4pp | 14.1%-4.7pp | 18.8%+6.4pp | 12.4%-8.0pp | 20.5%-4.0pp | 24.4%+5.7pp | 18.7%+6.5pp | 12.3%+9.7pp | 2.5%+1.7pp | 0.9% |
Similar Companies
Where Pacific Health Ranks
Frequently Asked Questions
What is Pacific Health's annual revenue?
Pacific Health (PFHO) reported $6.7M in total revenue for fiscal year 2025. This represents a 10.7% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.
How fast is Pacific Health's revenue growing?
Pacific Health (PFHO) revenue grew by 10.7% year-over-year, from $6.1M to $6.7M in fiscal year 2025.
Is Pacific Health profitable?
Yes, Pacific Health (PFHO) reported a net income of $1.4M in fiscal year 2025, with a net profit margin of 20.7%.
What is Pacific Health's EBITDA?
Pacific Health (PFHO) had EBITDA of $1.0M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.
What is Pacific Health's operating margin?
Pacific Health (PFHO) had an operating margin of 14.9% in fiscal year 2025, reflecting the profitability of core business operations before interest and taxes.
What is Pacific Health's net profit margin?
Pacific Health (PFHO) had a net profit margin of 20.7% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.
What is Pacific Health's return on equity (ROE)?
Pacific Health (PFHO) has a return on equity of 10.6% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.
What is Pacific Health's free cash flow?
Pacific Health (PFHO) generated $1.1M in free cash flow during fiscal year 2025. This represents a 70.8% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.
What is Pacific Health's operating cash flow?
Pacific Health (PFHO) generated $1.2M in operating cash flow during fiscal year 2025, representing cash generated from core business activities.
What are Pacific Health's total assets?
Pacific Health (PFHO) had $13.5M in total assets as of fiscal year 2025, including both current and long-term assets.
What are Pacific Health's capital expenditures?
Pacific Health (PFHO) invested $23K in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.
What is Pacific Health's current ratio?
Pacific Health (PFHO) had a current ratio of 34.45 as of fiscal year 2025, which is generally considered healthy.
What is Pacific Health's debt-to-equity ratio?
Pacific Health (PFHO) had a debt-to-equity ratio of 0.03 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.
What is Pacific Health's return on assets (ROA)?
Pacific Health (PFHO) had a return on assets of 10.3% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.
What is Pacific Health's Altman Z-Score?
Pacific Health (PFHO) has an Altman Z-Score of 22.69, placing it in the Safe Zone (low bankruptcy risk). The Z-Score combines five financial ratios (working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets) to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.
What is Pacific Health's Piotroski F-Score?
Pacific Health (PFHO) has a Piotroski F-Score of 6 out of 7 computable signals; 2 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.
Are Pacific Health's earnings high quality?
Pacific Health (PFHO) has an earnings quality ratio of 0.84x, considered mixed quality. This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.
Can Pacific Health cover its interest payments?
Pacific Health (PFHO) has an interest coverage ratio of 657.71x, meaning it can comfortably cover its interest obligations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.